Signal transducer and activator of transcription (Stat) 5 regulates growth, differentiation, and survival of mammary and hematopoietic cells. The role of Stat5 in breast cancer has not been established, although Stat5 is critical for some hematopoietic malignancies. We detected for the first time that Stat5b is constitutively activated in human breast cancer cell lines, and analysed the role of Stat5 in estrogen receptor(ER)-positive breast cancer cell lines using dominant-negative variants of Stat5. Two distinct carboxyl-truncated Stat5a derivatives were generated. Stat5aD740 corresponded to a naturally occurring alternative splice variant, and Stat5aD713 was analogous to an 80 kDa Stat5a product of a nuclear protease. Stat5aD740 and Stat5aD713 displayed comparable dominant-negative properties and suppressed transcriptional activity of wildtype Stat5a and Stat5b equally well. Cotransfection experiments revealed that Stat5aD740 completely blocked transcriptional activity of endogenous estrogen receptor in T47D and MCF7 cells, and of both ERa and ERb in COS-7 cells. Stat5aD740 was selected for adenoviral delivery, and high-efficiency expression of tyrosine phosphorylated Stat5aD740 was achieved in infected cells. Adenoviral-mediated Stat5aD740 induced apoptosis in T47D cells but not in caspase-3-negative MCF7 cells. The present study indicates that overexpression of a dominantnegative variant of Stat5 suppresses ER transcriptional activity and induces apoptosis in estrogen-responsive breast cancer tissue culture cells.
Introduction
Polypeptide hormones, cytokines, and growth factors activate signal transducer and activator of transcription (Stat) proteins to regulate a variety of cellular functions, including differentiation, proliferation, and survival (Ihle, 1996; Bromberg and Darnell, 2000; Buettner et al., 2002) . Stat5a was originally identified as a mammary gland factor activated by prolactin (Wakao et al., 1994) , and a second highly homologous Stat5b gene that is approximately 95% similar at the amino-acid level was later identified, with largely overlapping function (Kazansky et al., 1995 , Liu et al., 1995 . Subsequent studies have shown that Stat5 homologues are stimulated by a number of cytokines and growth factors, including erythropoietin, thrombopoietin, growth hormone, epidermal growth factor, plateletderived growth factor, insulin, and many of the interleukins and colony-stimulating factors (Grimley et al., 1999) . Stat5 is considered as a survival factor for hematopoietic cells and has been implicated in the progression of leukemias (Lacronique et al., 1997; Nieborowska-Skorska et al., 1999; Buettner et al., 2002) . Several lines of evidence support a tumor promoting role of Stat5 in cells of lymphoid and myeloid origin. For instance, upon activation by tyrosine kinases, cell cycle-associated genes such as cyclin D1, Bcl-X L , and p21 WAF1/CIPI are regulated by Stat5 in hematopoietic cells (Matsumura et al., 1997 , Socolovsky et al., 1999 . Specifically, Stat5 proteins serve an antiapoptotic function important for the growth-promoting effects of erythropoietin, interleukin-2 (IL2), IL3, and granulocyte colonystimulating factor (G-CSF) (Dong et al., 1998; Bittorf et al., 2000) and is critical for Bcr-Abl-and Tel-Jak2-induced leukemogenesis (Lacronique et al., 1997; Nieborowska-Skorska et al., 1999; Buettner et al., 2002) .
Stat5 is also well established to be a key factor for mammary epithelial cell growth and differentiation. Prolactin receptor signal transduction through the Jak2-Stat5 pathway has been considered to be essential for proliferation and differentiation of normal mammary epithelial cells (Hennighausen et al., 1997; Watson, 2001) . As a downstream mediator of prolactin and EGF effects in the mammary gland, Stat5 is also a candidate mediator of the mammary-tumor-promoting effect of these factors (Petersen and Haldosen, 1998) . Elevated Stat activation has been described in human breast tumors (Watson and Miller, 1995) , and we have observed prolactin activation of Stat5 in T47D and MCF7 cells (Schaber et al., 1998; Yamashita et al., 2001) .
Besides, the study of differentiation-specific gene expression in mammary epithelial cells has exposed molecular mechanisms governing the cooperation between steroid hormone receptors and Stat-mediated pathways (Stoecklin et al., 1999) . The glucocorticoid receptor may act as a transcriptional coactivator for Stat5 and can enhance Stat5-dependent transcription of the b-casein gene promoter (Stocklin et al., 1996) . Crosstalk between estrogen receptor (ER) and Stat5 was also reported (Stoecklin et al., 1999; Bjornstrom et al., 2001; Faulds et al., 2001) . Estrogens are potent mitogens in the mammary gland, where they are obligatory for normal development as well as for induction and progression of breast cancer. Both ERa and ERb are expressed in mammary epithelial cells during lactation as well as Stat5 (Saji et al., 2000) . In addition, ER-positive breast cancer cells such as T47D and MCF7 also express Stat5. To analyse the functional interactions between Stat5 and ER is important to understand the role of Stat5 in breast cancer.
The present study detected for the first time that Stat5b is constitutively activated in human breast cancer cell lines. Two carboxyl-truncated Stat5a variants, Stat5aD740 and Stat5aD713, both displayed constitutive and sustained DNA-binding activity and presented equivalent dominant-negative effects on both Stat5a-and Stat5b-mediated transcription. Moreover, Stat5a-D740 completely blocked transcriptional activity of endogenous ER in T47D and MCF7 cells, and that of ERa and ERb in COS-7 cells. To address the role of Stat5 in progression of Stat5-activated, ER-positive breast cancer cells, we utilized adenoviral gene delivery to achieve high-efficiency expression of dominantnegative Stat5. Adenoviral-mediated Stat5aD740 induced apoptosis in T47D cells, but not in caspase-3-negative MCF7 cells. The present study indicates that overexpression of a dominant-negative variant of Stat5 suppresses ER transcriptional activity and induces apoptosis in estrogen-responsive breast cancer tissue culture cells.
Results

Stat5b is constitutively tyrosine phosphorylated in human breast cancer cell lines
We analysed the expression and tyrosine phosphorylation status of Stat5a and Stat5b in various human breast cancer cell lines. MCF7, T47D, SK-BR-3, BT-20, and MDA-MB-231 cells were cultured in the presence of 10% fetal calf serum (FCS) and exponentially growing cells were harvested. Cells (2 Â 10 8 ) were lysed and immunoprecipitated. Stat5 proteins were separated on SDS-PAGE and immunoblotted with specific anti-Stat5 antibodies or phosphotyrosine antibodies. Stat5a was expressed but not detectably phosphorylated on tyrosine in all cell lines ( Figure 1a , top and second panels). In contrast, Stat5b was constitutively phosphorylated on Y699 in all cell lines ( Figure 1a , third and bottom panels). We concluded from immunoblotting that Stat5b was the predominantly activated form of Stat5 in exponentially growing human breast cancer cell lines.
ERa and ERb are expressed in proliferating T47D and MCF7 cells T47D and MCF7 cells are well-characterized ERpositive breast cancer cell lines. To verify the expression status of ERa and ERb in these cell clones that we used in this study, cells were cultured in the presence of 10% FCS and exponentially growing cells were harvested. Cells (2 Â 10 8 ) were lysed, and ERa and ERb were individually immunoprecipitated and subjected to SDS-PAGE. Immunoblotting with specific anti-ER antibodies revealed that both ERa and ERb were expressed in T47D and MCF7 cells (Figure 1b ).
Stat5b is constitutively tyrosine and serine phosphorylated in proliferating T47D and MCF7 cells
We then analysed the expression and phosphorylation status of Stat5a and Stat5b in T47D and MCF7 cells. Cells that had been cultured in the continuous presence of 10% FCS were harvested. Immunoprecipitated Stat5 proteins were separated on SDS-PAGE and immunoblotted with specific anti-Stat5 antibodies or phosphospecific antibodies. Stat5a was expressed but not detectably phosphorylated on tyrosine or serine residues ( Figure 1c , lanes 1 and 2, top, third, and bottom panels). In contrast, Stat5b was constitutively phosphorylated on both Y699 and S730 (Figure 1c , lanes 3 and 4, second, third, and bottom panels). We concluded from immunoblotting that Stat5b was the predominantly activated form of Stat5 in exponentially growing T47D and MCF7 cells.
Characterization of tyrosine phosphorylation of two distinct C-terminal deletion variants of Stat5a in COS-7 cells
We evaluated expression and extent of inducible tyrosine phosphorylation of two carboxyl-truncated Stat5a variants, Stat5aD740 or Stat5aD713, in transfected COS-7 cells. The analysis of proteins from whole cell lysates verified the expression of Stat5 variants, migrating at expected molecular sizes of 94 kDa for wild-type Stat5a, 86 kDa for Stat5aD740, and 80 kDa for Stat5aD713 (Figure 2a, upper panel) . Furthermore, phosphotyrosine immunoblotting of replicate samples showed that, like wild-type Stat5a, both Stat5aD740 and Stat5aD713 became inducibly tyrosine phosphorylated on residue Y694 in response to PRL (Figure 2a , lower panel). Stat5aD740 and Stat5aD713 were more highly phosphorylated than wild-type Stat5a relative to the amount expressed (Figure 2a, upper panel vs lower panel) . From this analysis, we concluded that Dominant-negative Stat5 induces apoptosis in T47D cells H Yamashita et al the expression plasmids encoded the appropriate proteins.
Evaluation of DNA-binding activities of Stat5aD740 and Stat5aD713
When tested for their ability to interact with DNA in electrophoretic mobility shift assay (EMSA), Stat5a-D740 and Stat5aD713 both displayed markedly increased DNA-binding activity relative to that of wild-type Stat5a (Figure 2b ). Nuclear DNA-binding activity of cells transfected with wild-type Stat5a reached maximum levels within 20 min (0.3 h) of PRL stimulation, remained detectable for 8 h, but was completely downregulated after 24 h of continuous PRL treatment (Figure 2b, upper left panel) . In contrast, cells transfected with Stat5aD740 or Stat5a-D713 showed markedly elevated binding already after 20 min of PRL stimulation, and nuclear-binding activity continued to rise for 8 h and remained detectable at 24 h (Figure 2b , upper middle and right panels, respectively).
We then extended the analysis by establishing that sustained DNA-binding activity of variants Stat5aD740 and Stat5aD713 could at least in part be attributed to a reduced rate of signal decay. When transfected COS-7 cells were stimulated with PRL for 20 min, washed twice with PBS, and then incubated in PRL-free medium for up to 24 h, both Stat5a variants Stat5aD740 and Stat5aD713 displayed significantly prolonged DNA binding for up to 8 h, whereas wild-type Stat5a DNAbinding decayed completely within the first 2 h of PRL removal (Figure 2b , lower three panels). Based on these experiments, we concluded that Stat5aD740 and Stat5a-D713 displayed equal DNA-binding capacities that were markedly elevated relative to that of wild-type, and that the increased DNA binding was associated with reduced off-rate of signal. (c) Stat5b is constitutively tyrosine and serine phosphorylated in T47D and MCF7 cells by immunoblotting. Exponentially growing cells in RPMI-1640 containing 10% FCS were harvested and equal amounts of total protein from whole cell lysates were IP with aStat5a or a-Stat5b antibodies. Parallel samples were blotted for either a-Stat5a or a-Stat5b, antiphosphotyrosine (a-pY694/pY699), and antiphosphoserine (a-pS725/pS730) antibodies Dominant-negative effects of Stat5aD740 and Stat5a-D713 were also confirmed in MCF7 cells (Figures 3c  and d) . Wild-type Stat5a and Stat5b mediated 70-and Based on these experiments, we concluded that Stat5aD740 completely suppressed transcriptional activity of both ERa and ERb in COS-7 cells.
Stat5aD740 completely blocks transcriptional activity of endogenous ER in T47D and MCF7 cells
We then tested whether Stat5aD740 suppressed estrogen-responsive gene transcription in ER-positive breast cancer cells. To analyse the transcriptional activity of endogenous ER in T47D and MCF7 cells, ERE-tk-luc, an ERE luciferase reporter construct with tk promoter that does not require the AF1 activity of ER, was used as a reporter gene (Cowley and Parker, 1999) , because this reporter was more responsive to E2 in these cells than the ERE-TATA-luc reporter gene used for the COS-7 cell studies above (data not shown). In T47D 
Adenoviral infectivity of T47D and MCF7 cells
In order to assess the role of Stat5 in the growth regulation of breast cancer cells, we selected to use adenoviral gene delivery to effectively achieve active dominant-negative Stat5. To establish appropriate conditions and the adenoviral infectivity of T47D and MCF7 cells, cultures were exposed to AdenoLacZ at various multiplicities of infection (MOI). At 24 h after infection, positive staining was observed in 75% of cells infected at MOI 10, in 90% of cells infected at MOI 20, and in 100% of cells infected at MOI 50 in both T47D and MCF7 cells (data not shown). Even higher levels of infectivity were detected when b-galactosidase levels were visualized 48 h after exposure to virus, and cultures of cells infected at MOI 10, 20, or 50 showed dose-dependent degree of positive staining. There were no detectable morphological changes in T47D or MCF7 cells even after 48 h of infection with AdenoLacZ at MOI values as high as 50. Thus, adenoviral gene delivery into T47D and MCF7 cells using human adenovirus 5 was highly feasible. COS-7 cells were transfected with expression plasmids encoding a 3ERE-TATA-luc reporter gene, the PRL receptor, a control pRL-TK Renilla luciferase vector, ERa (1 ng) (a) or ERb (1 ng) (b), and wild type of Stat5a (0.5 mg), Stat5b (0.5 mg), or Stat5aD740 (0.5 mg) as indicated. Cells were treated in the absence (À) or presence (+) of 17b-estradiol (E2; 10 nm) and/or PRL (10 nm) for 16 h in a serum-free medium. Dual-luciferase reporter assay was performed using cell extracts, and the ratios of firefly luciferase to Renilla luciferase activities are shown. The mean values of three independent experiments are presented, and s.e. values are indicated by bars. (c and d) T47D cells (c) or MCF7 cells (d) were transfected with expression plasmids encoding an ERE-tk-luc reporter gene, the PRL receptor, a pRL-TK vector, and wild type of Stat5a (0.5 mg), Stat5b (0.5 mg), or Stat5aD740 (0.5 mg). Cells were treated in the absence (À) or presence (+) of 17b-estradiol (E2; 10 nm) and/or PRL (10 nm) for 16 h in a serum-free medium. Dualluciferase reporter assay was performed using cell extracts, and the ratios of firefly luciferase to Renilla luciferase activities are shown. The mean values of three independent experiments are presented, and s.e. values are indicated by bars. (e) T47D cells were transfected with expression plasmids encoding the PRL receptor and wild type of Stat5a, Stat5b, or Stat5aD740. Cells were treated in the presence of 17b-estradiol (E2; 10 nm)) with or without PRL (10 nm) for 16 h in a serum-free medium. Total RNA was extracted and semiquantitative RT-PCR was performed. Representative figures of one of the three independent experiments are shown Dominant-negative Stat5 induces apoptosis in T47D cells H Yamashita et al
Generation of recombinant AdStat5aD740 adenovirus
We selected variant Stat5aD740 for incorporation into an adenoviral vector for functional testing, because Stat5aD740 represented a natural splice variant cloned from mammary epithelial cells (Kazansky et al., 1995 
Adenoviral Stat5aD740 binding to DNA is stimulated by serum or prolactin
We next examined whether adenoviral Stat5aD740 displayed DNA-binding activity. For these studies, nuclear extracts were prepared from MCF7 cells infected with Adcontrol or AdStat5aD740 at MOI values of 1 or 10, followed by culture in the presence of 10% FCS, or during serum-free conditions for up to 5 days in the absence or presence of PRL. Adenoviral Stat5aD740 binding to a b-casein promoter probe was analysed by EMSA. DNA binding was not detectable in mock-or Adcontrol-infected cells (Figure 5d, lanes 1-3) , whereas DNA binding was observed in cells infected with AdStat5aD740 growing in a medium containing 10% FCS (lanes 4 and 5) or in serum-free medium after short-term stimulation with PRL (lanes 8 and 9, lanes 12 and 13). Particularly, strong signals were observed in nuclear extracts from PRL-stimulated cells, whereas binding of Stat5aD740 to the b-casein promoter probe in cells continuously exposed to FCS was less pronounced, possibly reflecting partial downregulation of signal during chronic activation (Figure 5d , lane 5). Nonetheless, these experiments established that phosphorylation and DNA binding of adenoviral Stat5aD740 could be stimulated by either serum or PRL.
Dominant-negative Stat5 inhibits growth of T47D cells
To assess the role of Stat5 in the growth of ER-positive breast cancer cells, dominant-negative Stat5 was introduced into proliferating T47D cells. Cells were exposed to either mock infection, Adcontrol, or AdStat5aD740 at MOI 10 and incubated for 4 days in a medium containing 10% FCS, and cell growth was measured using an MTT-based cell proliferation assay (Figure 6a) . Interestingly, overexpression of Stat5aD740 produced a significant 55% decrease in cell number when compared to cells infected with Adcontrol (Figure 6a , right two bars, P ¼ 0.0002), while the infection of Adcontrol did not affect cell number when compared to mock-infected cells (Figure 6a , left two bars). Parallel studies were performed to determine whether dominant-negative Stat5 would affect estrogen-induced growth of T47D cells when cells were cultured in medium with charcoal/dextran-treated, estrogen-free FCS. Interestingly, dominant-negative Stat5 completely blocked estrogen-induced growth of T47D cells and further suppressed cell growth (Figure 6b ). Estrogen (E2; 10 nm) stimulated growth of mock-infected cells by 60% (Figure 6b , bars 1 and 2). Infection with Adcontrol adenovirus had no effect on the growth of estrogenstimulated cells, whereas the number of AdStat5aD740-exposed cells was consistently and significantly decreased by 60% over that of Adcontrol-infected cells after 4 days (Figure 6b , bars 3 and 4, Po0.0001). Collectively, these results suggested that dominantnegative Stat5 inhibited the growth of T47D cells, and that this effect could not be overcome by estrogen treatment.
Dominant-negative Stat5 does not inhibit growth of MCF7 cells
Similar cell proliferation experiments were carried out using MCF7 cells. Cells were exposed to either mock infection, Adcontrol, or AdStat5aD740 and incubated for 4 days in a medium containing 10% FCS (Figure 6c ) or charcoal/dextran-treated FCS in the absence or presence of E2 (Figure 6d) . Intriguingly, overexpression of Stat5aD740 did not inhibit the growth of MCF cells, but instead stimulated cell growth by approximately 1.6-fold when compared to mock-infected cells or cells infected with Adcontrol when cultured in a medium containing 10% FCS (Figure 6c) . Likewise, similar stimulation of growth by Stat5aD740 overexpression was observed when cultured in a medium containing charcoal/dextran-treated FCS in the presence of E2 (Figure 6d) . Thus, dominant-negative Stat5 did not inhibit but instead supported growth of MCF7 cells.
Dominant-negative Stat5 induces apoptosis in T47D cells
We then analysed whether dominant-negative Stat5 induced apoptosis in T47D cells by TdT-mediated dUTP-digoxygenin nick-end labeling (TUNEL) assay. Cells were either mock-infected or infected with Adcontrol or AdStat5aD740 at MOI 10 and cultured in a medium containing 10% FCS. Examination of Marked morphological changes such as shrunken cells were also evident and most cells were detached in the medium or easily detachable in parallel samples infected with AdStat5aD740 for 96 h, whereas mock-infected or Adcontrol-infected cells showed continuous growth (Figure 7a , upper panels). These results indicated that dominant-negative Stat5 induced apoptosis in T47D cells.
Caspase-3 is activated by overexpression of dominantnegative Stat5 in T47D cells but not in MCF7 cells
As dominant-negative Stat5 induced apoptosis in T47D cells, but not in caspase-3-negative MCF7 cells, caspase-3-mediated cell death was investigated as a possible mechanism for selective apoptosis induction by dominant-negative Stat5. Therefore, we specifically determined whether caspase-3 was activated in response to dominant-negative Stat5 in T47D cells. Cells were either mock-infected or infected with Adcontrol or AdStat5a-D740 at MOI 10 and cultured in a medium containing 10% FCS. Activity of apoptosis-specific intracellular caspase-3 was analysed. At 24 h after infection, moderate green fluorescence staining was observed in the cytoplasm of T47D cells infected with AdStat5aD740, whereas only background fluorescence staining was seen in mock-infected cells or in cells infected with Adcontrol (data not shown). The increased green fluorescence staining was markedly enhanced 30 h after infection with AdStat5aD740, while only background fluorescence staining remained detectable in mock-infected or Adcontrol-infected cells (Figure 7b , second panels). Fluorescence staining was not detected in MCF7 cells infected with either mock, Adcontrol, or AdStat5aD740 for up to 48 h (Figure 7b , bottom panels), confirming that MCF7 cells are deficient in functional caspase-3. Morphological changes were not apparent in parallel samples of T47D cells infected with AdStat5aD740 compared with those of mock-or Adcontrol-infected cells when cultured for 30 h (Figure 7b , top panels). From these analyses, we concluded that dominant-negative Stat5 induced apoptosis in T47D cells through the caspase-3-mediated pathway.
Discussion
The present study detected for the first time that Stat5b is constitutively activated in human breast cancer cell lines. Two naturally occurring, C-terminally truncated forms of Stat5a, Stat5aD740, and Stat5aD713 displayed comparable dominant-negative properties, and both suppressed transcriptional activity of wild-type Stat5a and Stat5b equally well. Intriguingly, Stat5aD740 completely blocked transcriptional activity of endogenous ERs in T47D and MCF7 cells, as well as the activities of both ERa and ERb when tested individually in COS-7 cells. High-efficiency adenoviral delivery of Stat5aD740 into T47D and MCF7 cells was associated with selective apoptosis induction in T47D cells, but not in MCF7 cells. Stat5aD740-induced apoptosis in T47D cells correlated with the caspase-3-mediated pathway, while the lack of functional caspase-3 in MCF7 cells may explain the different biological response to dominant-negative Stat5 by the two cell lines. Overexpression of a dominant-negative variant of Stat5 suppresses ER transcriptional activity and induces apoptosis in estrogen-responsive breast cancer tissue culture cells.
Constitutively activated Stat3 has been demonstrated to directly contribute to oncogenesis by stimulating cell proliferation and preventing apoptosis in breast cancer and head and neck carcinoma (Buettner et al., 2002) . Constitutive activation of Stat5 is also present in a variety of hematopoietic malignancies including chronic myelogenous leukemia, and we detected that Stat5b is constitutively activated in human breast cancer cell Previous work had demonstrated that Stat5 is expressed and is active in breast cancer cell lines (DaSilva et al., 1996; Schaber et al., 1998) . Specifically, in quiescent, serum-deprived near-confluent cultures of T47D and MCF7 cells, Stat5b was preferentially tyrosine phosphorylated in response to prolactin. Examination of low-density cultures of exponentially growing T47D and MCF7 cells now allowed us to extend these findings to include constitutive tyrosine and serine phosphorylation of Stat5b, but not Stat5a. Interestingly, Stat3 is not constitutively activated in these cells. Dominant-negative mutants are useful for analysing gene function in human cancer cells. A common feature of dominant-negative Stat5 is the partial or complete loss of the C-terminal transactivation domain. In the literature, the following forms have been described: D750 (Moriggl et al., 1996) , D740 (Kazansky et al., 1995) , D713 (Wang et al., 1996) , D683 (Mui et al., 1996) . D750, D740, and D713 retain the conserved tyrosine residue needed for dimerization and DNA binding. To select the most effective dominant-negative Stat5 variant for incorporation into human breast cancer cells, we first assessed the dominant-negative effect of the most advantageous Stat5 variants. Since mutant Stat5aD740 was based on a naturally occurring alternative splice variant (Kazansky et al., 1995; Wang et al., 1996) , and mutant Stat5aD713 was analogous to an 80 kDa Stat5 product of a nuclear protease (Meyer et al., 1998) , these two most physiologically relevant forms were selected for comparison testing of their dominant-negative properties.
The observed comparable efficiencies of the two different variants of carboxyl-truncated dominant-negative Stat5 was not expected, since the two forms differ with regard to regulatory serine phosphorylation sites. Specifically, mutant Stat5aD740 lacks residue Ser779, a phosphorylation site that is unique to Stat5a, but retains Ser725, a second phosphorylation site that is also present in Stat5b (Beuvink et al., 2000; Yamashita et al., 1998 Yamashita et al., , 2001 ). Stat5aD713, in contrast, lacks both serine phosphorylation sites Ser725 and Ser779. Stat5a-D740 and Stat5aD713 retain residue Tyr694, the phosphorylation site that is required for dimerization and DNA binding. Elevated and sustained DNA-binding activity of dominant-negative mutant 
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Stat5aD750 was previously reported (Moriggl et al., 1996) . Our analysis showed that Stat5aD740 and Stat5a-D713 displayed equivalent dominant-negative effects against wild-type Stat5a and Stat5b, and displayed equally sustained DNA-binding activities. Loss of structural elements within the C-terminal region of Stat5a that control signal decay rate may furthermore significantly contribute to the dominant-negative properties of this type of Stat5-variants, by combining the inability to transactivate with increased DNA-binding activity.
In the case of Stat1 and Stat3, serine phosphorylation appears to be required for maximal transcriptional activation (Wen et al., 1995) , and constitutive serine phosphorylation of Stat1 and Stat3 in B lymphocytes from patients with chronic lymphocytic leukemia has been predicted to correlate with hyperactivation of these transcription factors (Frank et al., 1997) . The regulatory role of serine phosphorylation of Stat5 has yet to be clearly defined. Stat5 serine phosphorylation may regulate protein interactions that result in positive as well as negative effects, depending on cell type and promoter context Yamashita et al., 2001) . The functional significance of constitutive Stat5 serine phosphorylation in T47D and MCF7 cells therefore remains to be established.
Crosstalk has been demonstrated between Stat5 and steroid hormone receptors such as glucocorticoid receptor, ER, and thyroid hormone receptor (Stocklin et al., 1996; Favre-Young et al., 2000; Bjornstrom et al., 2001; Faulds et al., 2001) . It has been established that the glucocorticoid receptor acts as a transcriptional coactivator for Stat5 and enhances Stat5-dependent transcription of the b-casein gene promoter (Stocklin et al., 1996) . Furthermore, two groups have demonstrated that Stat5a induction of the b-casein gene promoter was repressed by ERa activation (Stoecklin et al., 1999; Faulds et al., 2001) , although one study reported potentiation of Stat5 on the same promoter (Bjornstrom et al., 2001) . We have also determined that induction of the b-casein gene promoter by either Stat5a or Stat5b is suppressed by ERb activation in transfected COS-7 cells (data not shown). Although these results strongly suggested functional interactions between Stat5 and ER signaling, previous studies have focused on the effect of ER on transcriptional activity of Stat5.
Since both T47D and MCF7 cells are ER-positive breast cancer cell lines, we specifically focused on determining the impact of Stat5 and dominant-negative Stat5 on ER activity. The most important observation from these ER reporter gene experiments was that Stat5aD740 completely blocked transcriptional activity of endogenous ER in T47D and MCF7 cells, as well as that of both ERa and ERb in COS-7 cells. These results were further confirmed by the reduced endogenous PR expression in Stat5aD740-transfected T47D cells. In contrast, wild-type Stat5a and Stat5b did not systematically affect ER activity in these cells. Stoecklin et al. reported that increasing amounts of Stat5a negatively interfere with ERa-mediated induction in COS-7 cells. Furthermore, different types of interactions between Stat5 and glucocorticoid receptors occur depending on the amount of transfected expression vectors (Doppler et al., 2001) . Further studies are needed to identify the molecular mechanisms involved in this complete suppression of ER transcriptional activity by Stat5aD740. Two studies suggest that the interactions between ERs and Stat5 involved direct physical contact via the ER DNA-binding domain (Bjornstrom et al., 2001; Faulds et al., 2001 ). In addition, putative Stat5 response elements were recently identified in the promoter regions of ERa and ERb, and prolactin stimulates ER expression at the level of transcription in corpus luteum (Frasor et al., 2001) .
Finally, our results provide evidence that dominantnegative Stat5 induces apoptosis through the caspase-3-mediated pathway in T47D cells, an effect that may be because of a combined inhibition of both Stat5 and ER signaling pathways. On the other hand, dominantnegative Stat5 did not inhibit the growth of MCF7 cells although both wild-type Stat5 and ER activities were suppressed in MCF7 cells as well as in T47D cells. MCF7 cells are deficient in caspase-3 owing to a 47-bp deletion within exon 3 of the CASP-3 gene, and this deletion abrogates translation of the CASP-3 mRNA (Janicke et al., 1998) . It is possible that the stimulation of growth in MCF7 cells after overexpression of Stat5aD740 was caused by Stat5aD740 itself. Since this carboxyl-truncated variant was cloned from the mammary gland of lactating rats (Kazansky et al., 1995) , it may have a function in mammary gland development and tumorigenesis. Human Stat5aD741 and human Stat5bD746, which are naturally occurring dominantnegative variants, are expressed at low levels or not at all in T47D and MCF7 cells (Yamashita H, unpublished results) . Since the expression levels of wild-type Stat5b are much higher than those of the dominant-negative variants, these dominant-negative variants may have little effect against wild-type Stat5b or ER.
Recent studies have indicated that sole inhibition of the Stat5 signaling pathway may not be sufficient to induce apoptosis in hematopoietic cells. For instance, inhibition of either Stat5 or PI3 kinase alone did not affect IL-3-mediated survival or proliferation of BaF3 cells, but blockade of both Stat5 and PI3 kinase effectively induced apoptosis in these cells (Rosa Santos et al., 2000) . It was also reported that functional cooperation among Ras, Stat5, and P13 kinase was required for full oncogenic activities of Bcr-Abl in K562 cells (Sonoyama et al., 2002) . It is therefore possible that the effectiveness of dominant-negative Stat5 to induce apoptosis in T47D cells is in part be due to its ability to block ER activity. It is also possible that the induction of apoptosis in T47D cells occurred because of extremely high levels of expression of dominant-negative Stat5 through adenoviral delivery. Therefore, further study is needed to analyse the functional interactions between dominant-negative Stat5 and ER. Identifying the mechanisms of selective apoptosis induction by dominant-negative Stat5 is important in understanding the role of Stat5 in ER-positive breast cancer cell lines.
In conclusion, we have characterized two carboxyl-truncated dominant-negative variants of Stat5. Adenoviral-mediated dominant-negative Stat5 was highly expressed and activated in ER-positive T47D and MCF7 human breast cancer cells, in which Stat5b is constitutively activated. Dominant-negative Stat5 induced apoptosis via the caspase-3-mediated pathway in T47D cells through a mechanism that may involve inhibition of both Stat5 and ER signaling pathways. The present study indicates that overexpression of a dominant-negative variant of Stat5 suppresses ER transcriptional activity and induces apoptosis in estrogen-responsive breast cancer tissue culture cells.
Materials and methods
Plasmids and mutants
Expression plasmid p3PRLR was constructed as described (Yamashita et al., 1998) and contains a 2.7-kb human prolactin receptor cDNA (kindly provided by Paul A Kelly, Paris, France). Expression vectors for mouse Stat5a and mouse Stat5b (pXM-Stat5a/b; kindly provided by Xiuwen Liu and Lothar Hennighausen, Bethesda, MD, USA) have been described previously (Liu et al., 1995) . An expression vector for human ERa cDNA (pSG5/puromycine hERa full length) was kindly provided by Pierre Chambon (Strasbourg, France), and an expression vector for human ERb cDNA subcloned in pCXN2 was kindly provided by Masami Muramatsu (Saitama, Japan). The genomic (À344 to À1) b-casein gene promoter linked to the luciferase reporter gene (pZZ1; kindly provided by Bernd Groner, Freiburg, Germany) has been described previously (Yamashita et al., 1998) . Two ERE containing reporter plasmids, 3ERE-TATA-luc and ERE-tk-luc, were kindly provided by Malcolm G Parker (London, UK) (Cowley and Parker, 1999) . Expression vectors for Stat5aD740 and Stat5aD713 were generated by truncation after amino-acid residues Asn740 or Ala713 of pXM-Stat5a, respectively. The EcoRI-XbaI-digested PCR fragment amplified with 5 0 -TAA-TACGACTCACTATAGGG-3 0 (sense) and 5 0 -GCTCTA-GACTAGTTGGGTGGGTACATGTTG-3 0 (antisense for D740) or 5 0 -GCTCTAGACTAGGCATCTGTGGATGCAT-TG-3 0 (antisense for D713) primers were subcloned into EcoRI-XbaI-digested pXM-Stat5a. The DNA sequence of the resulting constructs, pXM-Stat5aD740 and pXM-Stat5aD713, was verified before use.
Cell culture and transfections
COS-7 cells (ATCC) were grown in Dulbecco's modified essential medium containing 10% FCS, 2 mm l-glutamine, and penicillin-streptomycin (50 IU/ml and 50 mg/ml, respectively) at 371C with 5% CO 2 . T47D, SK-BR-3, BT-20, and MDA-MB-231 cells (ATCC) were grown in RPMI-1640 containing 10% FCS, 2 mm l-glutamine, and penicillin-streptomycin (50 IU/ml and 50 mg/ml, respectively), at 371C with 5% CO 2 . MCF7 cells (ATCC) were grown in RPMI-1640 containing 10% FCS, 2 mm l-glutamine, 0.01 mg/ml bovine insulin and penicillin-streptomycin (50 IU/ml and 50 mg/ml, respectively), at 371C with 5% CO 2 . Cells were also cultured in a medium without phenol red containing 10% charcoal/dextran-treated FCS (HyClone Laboratories) to use estrogen-free medium. For expression analysis in COS-7 cells, transfections were performed with LipofectAMINE reagent (Life Technologies) using subconfluent cultures. A 2 mg measure of the prolactin receptor construct (p3PRLR) and 2 mg of either of plasmids pXM-Stat5a, pXM-Stat5aD740, or pXM-Stat5aD713 were used for 2 Â 10 6 cells in each transfection. For luciferase assays, FuGENE6 transfection reagent (Roche Molecular Biochemicals) was used for transfection into COS-7, T47D, and MCF7 cells. A measure of 2 ml of FuGENE6 reagent, 0.1 mg of plasmid pXM-Stat5a or pXM-Stat5b, 0.1 mg of p3PRLR, 0.2 mg of pZZ1, 2 ng of pRL-TK vector as an internal control reporter, and 0.1 or 0.4 mg of either pXMStat5aD740 or pXM-Stat5aD713 were used for analysing the transcriptional activity for b-casein gene promoter. In each experiment, the total amounts of DNA of individual wells were kept constant by adjusting with salmon sperm DNA. To detect the transcriptional activity for endogenous ERs, 2 ml of FuGENE6 reagent, 0.5 mg of plasmid pXM-Stat5a, pXMStat5b, or pXM-Stat5aD740, 0.1 mg of p3PRLR, 0.2 mg of 3ERE-TATA-luc or ERE-tk-luc, and 2 ng of pRL-TK vector as an internal control reporter were used. For COS-7 cells, 1 ng of either expression plasmid encoding ERa or ERb was added.
Solubilization of proteins, immunoprecipitation, and immunoblotting
Cells were treated in the absence or presence of human prolactin (PRL) (NIDDK-hPRL-SIAFP-B2, AFP-2969A; a gift from AF Parlow at the National Pituitary Hormone Program) for 20 min, pelleted by centrifugation and solubilized in lysis buffer containing 10 mm Tris-HCl, pH 7.6, 5 mm EDTA, 50 mm NaCl, 30 mm sodium pyrophosphate, 50 mm sodium fluoride, 1 mm sodium orthovanadate, 1% Triton X-100, 1 mm phenylmethylsulfonylfluoride (PMSF), 5 mg/ml aprotinin, 1 mg/ml pepstatin A, and 2 mg/ml leupeptin as described (Kirken et al., 1997b) . Equal amounts of total protein from whole cell lysates were prepared and used for SDS-PAGE. For immunoprecipitation from clarified cell lysates, polyclonal rabbit antisera (2 ml/ml) specific to peptides corresponding to the unique COOH-termini of Stat5a or Stat5b (Kirken et al., 1997a) , and rabbit polyclonal antibodies of ERa (H-184, Santa Cruz Biotechnology) or ERb (H-150, Santa Cruz Biotechnology) were used and captured after incubation with protein A-Sepharose beads (Pharmacia Biotech, Cat. # 17-0780-01). Immunoblotting was performed as described previously (Kirken et al., 1997b) using polyvinylidene difluoride (PVDF) membranes (Millipore, Cat. # 1PVH 00010), and antiphospho-Stat5a/b (Y694/Y699) monoclonal antibodies (UBI, Cat. # 05-495; 0.5 mg/ml), antiphospho-Stat5a/b (S725/S730) polyclonal rabbit antisera (1 : 5000 dilution) (Yamashita et al., 1998 ), anti-Stat5 monoclonal antibodies (Transduction Laboratories, Cat. # S21520; 250 mg/ ml), polyclonal rabbit antisera of Stat5a and Stat5b (1 : 3000 dilution), and polyclonal antibodies of ERa (H-184) and ERb (H-150) (1 : 200 dilution) as primary antibodies and horseradish peroxidase-conjugated goat antibodies to mouse or rabbit IgG as secondary antibodies in conjunction with enhanced chemiluminescence substrate mixture (Amersham, Cat. # RPN2106) as described previously (Yamashita et al., 1998) .
Electrophoretic mobility shift assay (EMSA)
Cells were treated in the absence or presence of human PRL as indicated, pelleted by centrifugation and immediately solubilized in EMSA lysis buffer and analysed as described earlier (Kirken et al., 1997b) .
32 P-labeled oligonucleotide corresponding to the prolactin response element (5 0 -agatttctaggaattcaaatc-3 0 ) of the rat b-casein gene was used. Polyacrylamide gels (4%) containing 5% glycerol and 0.25 Â TBE were prerun in 0.25 Â TBE buffer at 4-101C for 1.5 h at 300 V. After loading of samples, the gels were run at room temperature for approximately 3 h at 250 V. Gels were dried by heating under vacuum and exposed to X-ray film (X-Omat, Kodak).
Dual-luciferase reporter assay
One day after transfection, cells were stimulated with 10 nm human PRL and/or 17b-estradiol (E2) (Sigma) for 16 h in a serum-free medium and harvested. Dual-luciferase reporter assay (Promega, Cat. # E1910) was used for experiments to measure transcriptional activity using pRL-TK vector as an internal control. Assays were performed according to the manufacturer's instructions. Briefly, cells were washed with PBS and lysed in passive lysis buffer for 15 min and then centrifuged at 12 000 g for 30 s at 41C. Supernatants were used for dual-luciferase reporter assays for firefly luciferese activity and Renilla luciferese activity. Cell lysate (10 ml) was mixed with 100 ml of LAR II assay buffer. Firefly luciferase activity of each sample was determined by measuring luminescence for 10 s followed by adding 100 ml of Stop & Glo Reagent for measuring Renilla luciferese activity. To correct for differences in transfection efficiencies, firefly luciferase activities were normalized to Renilla luciferease activities in each individual sample.
Semiquantitative RT-PCR
One day after transfection, cells were stimulated with 17b-estradiol (E2) and/or 10 nm human PRL for 16 h in a serumfree medium and harvested. Total RNA was extracted using an absolutely RNA RT-PCR Miniprep Kit (Stratagene) according to the manufacturer's instructions. Total RNA (1 mg) was subjected to reverse transcription with oligo(dT) primer in a 25 ml reaction volume at 421C for 50 min. A volume of 1 ml of this reaction was analysed by PCR in a 25 ml reaction volume. One primer set termed 'PRAB' was used to detect products that contain both PRA and PRB cDNA, and the other set termed 'PRB' was used to detect products that only contain PRB cDNA. Primers for PCR were as follows: PRAB, 5 0 sense-CCTCGGACACCTTGCCTGAA and 3 0 antisense-CGCCAACAGAGTGTCCAAGAC (239 bp); PRB, 5 0 sense -TAGTGAGGGGGCAGTGGAAC and 3 0 antisense -AG-GAGGGGGTTTCGGGAATA (442 bp). PCR conditions were as follows: 941C for 5 min, 30 cycles of 941C for 30 s, 561C for 30 s, 721C for 60 s, followed by incubation at 721C for 5 min. PCR conditions were determined from the cycle curve. Each product (10 ml) were run on a 2% agarose gel, and the bands were visualized by ethidium bromide staining. As an internal control, a fragment of human GAPDH was amplified from parallel samples by PCR using the following primers: 5 0 sense-AAATCAAGTGGGGCGATGCTG and 3 0 antisense-GCAGAGATGATGACCCTTTTG (118 bp). The intensities of the PRAB, PRB, and GAPDH bands were quantified with NIH image.
Construction of recombinant adenovirus and infection procedures
EcoRI-XbaI-digested pXM-Stat5aD740 was subcloned into the BamHI site of AdCMV5 shuttle vector, which contains an inverted terminal repeat (ITR) of the adenovirus 5 genome, cytomegalovirus 5 (CMV5) promoter and enhancer, globin poly A, and 9.4-15.5 map unit of human adenovirus 5 genome (ADENO-QUEST, QUANTUM). The resulting AdCMV5Stat5aD740 plasmid was linearized by digesting with ClaI and cotransfected into 293A cells with a linearized vector containing an adenovirus 5 genome from which the El and E3 regions have been deleted (QBI-viral DNA; ADENO-QUEST, QUANTUM). Plaques were screened for the presence of Stat5aD740 sequences by using a set of primers that were 5 0 -TGGCTGAGAAGCACCAGAAGAC-3 0 and 5 0 -GCTGAGATGATGTCCGTGATGG-3 0 , for the absence of E1a sequence by using a set of primers that were 5 0 -GAGACATATCTGCCACGGAGG-3 0 and 5 0 -TTGGCATA-GAAACCGGACCCAAGG-3 0 , and for the presence of Stat5aD740 protein expression by Western blotting using anti-Stat5 antibodies. Three positive clones were further purified by plaque assay, and a purified viral plaque was amplified in 293A cells according to the manufacturer's instructions. High titer recombinant adenovirus was purified by double cesium chloride gradient and titration was performed by a tissue culture infectious dose 50 (TCID 50 ) method.
Control adenovirus (Adcontrol), an adenovirus vector d1312 containing no insert (Jones and Shenk, 1979) (kindly provided by Shiv Srivastava, Bethesda, MD, USA) was used, and AdenoLacZ, a b-galactosidase expressing replicationdeficient adenovirus, was amplified from QBI-infect+ (ADENO-QUEST, QUANTUM) and served for infectivity test.
Infection with recombinant adenovirus was accomplished by exposing cells to various doses of virus in a serum-free RPMI-1640 medium for 1.5 h followed by addition of a medium with or without 10% FCS. For immunoblotting and EMSA, 1 Â l0 6 cells were plated in 100-mm dishes and infected with adenovirus as indicated. To monitor adenovirus infectivity, cells were exposed to various levels of AdenoLacZ and incubated for 24 or 48 h. Cells were fixed and stained with X-gal for 2 h using an in situ b-galactosidase staining kit (Stratagene).
Cell proliferation assay
Cells (2000 cells/well) were plated in 96-well plates and incubated in RPMI-1640 without phenol red containing 10% FCS or 10% charcoal/dextran-treated FCS. Cells were then infected with AdStat5aD740 or Adcontrol adenovirus at MOI 10 and incubated in the presence or absence of l7b-estradiol (E2, 10 nm) for 4 days. Cell growth was measured using CellTiter 96 aqueous one solution (Promega) by incubating cells for 4 h with the reagent and recording absorbance at 490 nm with a 96-well plate reader.
TUNEL assay
Cells were cultured in RPMI-1640 containing 10% FCS, and infected with AdStat5aD740 or Adcontrol at MOI 10 for various time periods. A TUNEL method was used to evaluate apoptosis for the fragmentation assay with an In Situ Cell Death Detection kit (Roche Molecular Biochemicals). Briefly, cells were fixed for 1 h, then washed twice and TUNEL reaction mixture was added. After 1 h of incubation in a humidified chamber at 371C, cells were washed three times and analysed under a fluorescence microscope.
Caspase-3 activity assay
Cells were cultured in RPMI-1640 containing 10% FCS, and infected with AdStat5aD740 or Adcontrol at MOI 10 for various time periods. Caspase-3 activities were measured with a PhiPiLuxtG1D2 kit (MBL, Nagoya, Japan). Briefly, cells were washed with PBS and added substrate solution, supplied by the manufacturer, that contains the caspase-3-specific substrate. After 1 h of incubation in a 5% CO 2 incubator at 371C, cells were washed three times and the cleaved substrate at the amino-acid sequence of DEVDG1 was detected by fluorescence microscopy.
Abbreviations
Stat5, signal transducer and activator of transcription 5; PRL, prolactin; ER, estrogen receptor; ERE, estrogen-responsive element; E2, l7b-estradiol; PAGE, polyacrylamide gel electrophoresis; EMSA, electrophoretic mobility shift assay; PR, progesterone receptor.
